Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03059485 |
| Title | DC/AML Fusion Cell Vaccine vs DC/AML Fusion Cell Vaccine Plus Durvalumab vs Observation in Patients Who Achieve a Chemotherapy-induced Remission |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Dana-Farber Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Emory Winship Cancer Institute | WITHDRAWN | Atlanta | Georgia | 30033 | United States | Details |
| KU Cancer Center | WITHDRAWN | Westwood | Kansas | 66205 | United States | Details |
| Massachusetts General Hospital | ACTIVE_NOT_RECRUITING | Boston | Massachusetts | 02214 | United States | Details |
| Beth Israel Deaconess Medical Center | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Dana Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| University of Wisconsin Carbone Cancer Center | ACTIVE_NOT_RECRUITING | Madison | Wisconsin | 53792 | United States | Details |